Nitric oxide synthase is a cytochrome P-450 type hemoprotein - PubMed
- ️Wed Jan 01 1992
. 1992 Jul 28;31(29):6627-31.
doi: 10.1021/bi00144a001.
Affiliations
- PMID: 1379068
- DOI: 10.1021/bi00144a001
Nitric oxide synthase is a cytochrome P-450 type hemoprotein
K A White et al. Biochemistry. 1992.
Abstract
Nitric oxide has emerged as an important mammalian metabolic intermediate involved in critical physiological functions such as vasodilation, neuronal transmission, and cytostasis. Nitric oxide synthase (NOS) catalyzes the five-electron oxidation of L-arginine to citrulline and nitric oxide. Cosubstrates for the reaction include molecular oxygen and NADPH. In addition, there is a requirement for tetrahydrobiopterin. NOS also contains the coenzymes FAD and FMN and demonstrates significant amino acid sequence homology to NADPH-cytochrome P-450 reductase. Herein we report the identification of the inducible macrophage NOS as a cytochrome P-450 type hemoprotein. The pyridine hemochrome assay showed that the NOS contained a bound protoporphyrin IX heme. The reduced carbon monoxide binding spectrum shows an absorption maximum at 447 nm indicative of a cytochrome P-450 hemoprotein. A mixture of carbon monoxide and oxygen (80%/20%) potently inhibited the reaction (73-79%), showing that the heme functions directly in the oxidative conversion of L-arginine to nitric oxide and citrulline. Additionally, partially purified NOS from rat cerebellum was inhibited by CO, suggesting that this isoform may also contain a P-450-type heme. NOS is the first example of a soluble cytochrome P-450 in eukaryotes. In addition, the presence of FAD and FMN indicates that this is the first catalytically self-sufficient mammalian P-450 enzyme, containing both a reductase and a heme domain on the same polypeptide.
Similar articles
-
Pufahl RA, Marletta MA. Pufahl RA, et al. Biochem Biophys Res Commun. 1993 Jun 30;193(3):963-70. doi: 10.1006/bbrc.1993.1719. Biochem Biophys Res Commun. 1993. PMID: 7686757
-
Hurshman AR, Marletta MA. Hurshman AR, et al. Biochemistry. 1995 Apr 25;34(16):5627-34. doi: 10.1021/bi00016a038. Biochemistry. 1995. PMID: 7537092
-
Olken NM, Osawa Y, Marletta MA. Olken NM, et al. Biochemistry. 1994 Dec 13;33(49):14784-91. doi: 10.1021/bi00253a017. Biochemistry. 1994. PMID: 7527657
-
[Physiological and physiopathological aspects of nitric acid in mammalian tissues].
Molero-Leal M. Molero-Leal M. Invest Clin. 1998 Jun;39(2):125-54. Invest Clin. 1998. PMID: 9707923 Review. Spanish.
-
Ca2+/calmodulin-regulated nitric oxide synthases.
Schmidt HH, Pollock JS, Nakane M, Förstermann U, Murad F. Schmidt HH, et al. Cell Calcium. 1992 Jun-Jul;13(6-7):427-34. doi: 10.1016/0143-4160(92)90055-w. Cell Calcium. 1992. PMID: 1380405 Review.
Cited by
-
Dyson RM, Palliser HK, Latter JL, Kelly MA, Chwatko G, Glowacki R, Wright IM. Dyson RM, et al. PLoS One. 2015 Mar 25;10(3):e0121621. doi: 10.1371/journal.pone.0121621. eCollection 2015. PLoS One. 2015. PMID: 25807236 Free PMC article.
-
Nitric oxide-cyclic GMP signaling in stem cell differentiation.
Mujoo K, Krumenacker JS, Murad F. Mujoo K, et al. Free Radic Biol Med. 2011 Dec 15;51(12):2150-7. doi: 10.1016/j.freeradbiomed.2011.09.037. Epub 2011 Oct 6. Free Radic Biol Med. 2011. PMID: 22019632 Free PMC article. Review.
-
Cytoprotection behind heme oxygenase-1 in renal diseases.
Correa-Costa M, Amano MT, Câmara NO. Correa-Costa M, et al. World J Nephrol. 2012 Feb 6;1(1):4-11. doi: 10.5527/wjn.v1.i1.4. World J Nephrol. 2012. PMID: 24175236 Free PMC article.
-
Feedback inhibition of nitric oxide synthase activity by nitric oxide.
Assreuy J, Cunha FQ, Liew FY, Moncada S. Assreuy J, et al. Br J Pharmacol. 1993 Mar;108(3):833-7. doi: 10.1111/j.1476-5381.1993.tb12886.x. Br J Pharmacol. 1993. PMID: 7682140 Free PMC article.
-
Holden JK, Lim N, Poulos TL. Holden JK, et al. J Biol Chem. 2014 Oct 17;289(42):29437-45. doi: 10.1074/jbc.M114.595165. Epub 2014 Sep 6. J Biol Chem. 2014. PMID: 25194416 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources